[2] Steiner J，Guglin M. BNP or NTproBNP? A clinician's perspective [J]. Int J Cardiol, 2008，1 29(1): 5-14.
[2] Park SH，Lee SW，Lee SJ，et al. The associat ion between left ventricular hypertrophy and biomarkers in patients on continuous ambulatory peritoneal dialysis[J]. Korean Circ J, 2009, 39(11): 488-493.
[3] Wang AY，Lam CW，Yu CM，et al. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion，mortality，and adverse cardiovascular outcomes in chronic peritoneal dialysis patients[J]. J Am Soc Nephrol，2007, 18(1): 321-330.
[4] Madsen LH，Ladefoged S，Corell P，et al. N-terminal pro brain natriuretic peptide predicts mortality in patients with endstage renal disease in hemodialysis[J]. Kidney Int，2007，71 (6 ): 548-554.
[5] Trap J，Prez A，Naval I，et al. Nt-proBNP in haemodialysis patients: a preliminary study[J]. Scand J Clin Lab Invest，2008, 68(5): 415-420.
[6] 李杰，张启蒙，范敏华. N 端脑钠肽水平对血液透析患者容量 负荷的诊断价值[J]. 中国血液净化，2 011，1 0(7): 376-379.
[7] 黎磊石刘志红. 中国肾脏病学[M]. 北京: 人民军医出版社, 2008: 1328-1334.
[8] Morillas P，Castillo J，Quiles J，et al. Usefulness of NT-proBNP level for dignosing left ventricular hypertrophy in hypertensive patients: a cardiac maagnetic resonance study [J]. rev Esp Cardiol, 2008，6 1(9): 972-975.
[9] Melina G，Angeloni E，Benedetto U，et al. relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement[J]. J Heart Valve Dis，2010，19 (2): 171-176.
[10] Bargnoux AS，Klouche K，Fareh J，et al. Prohormone brain natriuretic peptide (proBNP ) ，BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration[J]. Clin Chem Lab Med, 2008, 46(7): 1019-1024.
[11] Yamazaki M，Ogawa T，Tamei N, et al，relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients [J]. Heart Vessels，2011，2 6(4): 421-427.
[12] 郑寅，匡鼎伟，李海明，等. 维持性血透患者N 端脑钠肽水平 的影响因素及其与心脏重构和心功能的关系[J]. 复旦学报, 2010, 37(3): 298-303.
[13] Spratt JC，Webb DJ，Shiels A，et al. Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects[J]. J renin Angiotensin Aldosterone Syst, 2001，2(4): 227-232.
[14] 李旭，曹宁，韩敬明，等. 左卡尼汀对维持性血液透析患者左 心肥厚的影响[J]. 实用医学杂志，2 009，2 5(5): 786-788.